How U.S. Marijuana Reclassification Could Help Cannabis Companies
Federal cannabis reclassification benefits cannabis companies by reducing regulatory barriers and enabling larger clinical trials. This shift could improve product quality and research funding. It marks a significant step toward evidence-based cannabis…
Apr 25 | Your CBD Store – CLINTON! WIN BIG! $$$ | Clinton, CT Patch
Retail CBD promotions highlight the gap between marketing and clinical evidence. Patients need clinical guidance when navigating CBD product quality. Retail events often emphasize incentives over health outcomes.
California Marks 10 Years of Cannabis Legalization Amid Illegal Market Struggle
California cannabis legalization 10 years provides key insights into patient safety and product quality. Despite legal access, the illegal market persists, impacting patients. Understanding these dynamics is crucial for improving cannabis access…
New Medical Cannabis Cultivation Facility Opens in Hopkins County
A new medical cannabis cultivation facility approval in Hopkins County marks an important step in expanding local production capacity. This approval can improve product availability and patient access to medical cannabis. The facility's adherence to…
Regulators Issue Strict Warning to Cannabis Companies on Compliance
Cannabis regulatory enforcement impact is critical for patient safety and product consistency. Regulators have issued strict warnings to cannabis companies about compliance. These actions affect patient access and supply chain security in medical…
Three closely linked X‐chromosomal genes potentially control sex determination in Cannabis sativa
This article explores cannabis sex determination genes that control plant sex expression. Understanding these genes is crucial for cultivation and cannabinoid consistency. The findings provide new insights into cannabis breeding strategies.
Clinical Review of 24 Week Cannabis Outcomes
This 24 week cannabis outcomes review highlights clinical evidence on CBD gummy product quality and dosing. Understanding these outcomes is essential for patient education and safe use. The focus on 24 week cannabis outcomes ensures evidence-based…
Cannabis flower crude extracts as belowground infochemicals shaping the chemotactic … – Nature
This research explores cannabis flower crude extracts as belowground infochemicals that influence soil microbiology and root interactions. These interactions may affect the phytochemical profile of medical cannabis products. Understanding cannabis flower…
Q&A with Scott Mazza, Founder of Vitality CBD | citybiz
This vitality cbd founder interview offers valuable insights into CBD product quality and market positioning. Understanding these aspects helps clinicians address patient questions effectively. The interview highlights emerging trends influencing patient…
How 2 Engineers Quietly Built a $1B California Cannabis Behemoth
California cannabis distribution consolidation significantly impacts product availability and quality. Clinicians observe these changes affecting patient treatment outcomes. Understanding this consolidation helps anticipate supply chain disruptions.
